Every Form 4 that Longeveron Inc. (LGVN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow LGVN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LGVN filings page.
Longeveron Inc. (symbol: LGVN) is the issuer of record for a Form 4 filing submitted to the SEC.
Longeveron Inc. (symbol: LGVN) is the issuer of record for a Form 4 filing submitted to the SEC.
Longeveron Inc. (symbol LGVN) reported that a director, identified as the reporting person, received an equity compensation award in the form of Class A Common Stock. On 2026-08-19, the reporting person acquired 36,000 shares through an award of time-based vesting Restricted Stock Units (RSUs) at a stated price of $0.00 per share.
After this grant, the reporting person directly holds 69,000 shares of Class A Common Stock, which the disclosure states includes RSUs subject to future vesting. The transaction is characterized as a grant, award, or other acquisition and was not reported as made pursuant to a Rule 10b5-1 trading plan.
Longeveron Inc. (symbol: LGVN) is the issuer of record for a Form 4 filing submitted to the SEC.
Longeveron Inc. (symbol: LGVN) is the issuer of record for a Form 4 filing submitted to the SEC.
Longeveron Inc. (symbol: LGVN) is the issuer of record for a Form 4 filing submitted to the SEC.
Longeveron Inc. (symbol: LGVN) is the issuer of record for a Form 4 filing submitted to the SEC.
Longeveron Inc. (LGVN) director Arjun JJ Desai reported an acquisition of 36,000 shares of Class A common stock on August 19, 2026. The transaction was a grant of time-based vesting Restricted Stock Units (RSUs) at a stated price of $0.00 per share, bringing Desai’s directly held position to 36,000 shares, which includes RSUs subject to future vesting.
Longeveron Inc. (symbol: LGVN) is the issuer of record for a Form 4 filing submitted to the SEC.
Longeveron Inc. (LGVN) reported that Chief Medical Officer Nataliya Agafonova received an equity compensation award. She was granted 286,000 shares of Class A Common Stock in the form of time-based vesting Restricted Stock Units (RSUs), acquired at a stated price of $0.00 per share as an award. After this grant, her directly held position is 716,914 shares of Class A Common Stock, which includes RSUs subject to future vesting.
Longeveron Inc. (LGVN) director Deborah Ascheim reported an acquisition of 36,000 shares of Class A Common Stock on 2026-08-19 through a grant/award, reflected at a price of $0.00 per share. The award represents time-based vesting Restricted Stock Units (RSUs) and includes RSUs subject to future vesting, bringing her reported direct holdings to 36,000 shares.
Longeveron Inc. (symbol: LGVN) is the issuer of record for a Form 4 filing submitted to the SEC.
Longeveron Inc. reported that Chief Scientific Officer and significant shareholder Joshua Hare received equity awards rather than making open-market purchases. He was granted 600,000 Class B common stock shares through time-based vesting RSUs. Following this award, he directly holds 1,321,796 Class B shares, including RSUs subject to future vesting.
He also received stock options on 400,000 Class B shares at an exercise price of $0.65 per share, vesting quarterly over a three-year period beginning on October 1, 2026 and expiring on July 6, 2036. Class B common stock is not registered under the Securities Exchange Act of 1934, has five votes per share, and is convertible into common stock on a one-for-one basis at the holder’s option.
Longeveron Inc. Chief Executive Officer Willard Stephen H reported a tax-related share disposition. On July 1, 2026, 18,046 shares of Class A Common Stock were withheld at an average price of $0.7291 per share to cover tax obligations tied to a restricted stock unit vesting.
This was not an open-market sale but a payment of tax liability by delivering shares. After the withholding, the CEO directly holds 771,681 shares of Longeveron Inc., and the position also includes restricted stock units that remain subject to future vesting.
Longeveron Inc. Chief Financial Officer Lisa Locklear reported a tax-related share disposition. On the vesting of a restricted stock unit (RSU) award, 22,505 shares of Class A Common Stock were withheld at $0.7291 per share to satisfy tax obligations. This was not an open-market sale, but an automatic tax-withholding mechanism. After this RSU-related withholding, Locklear directly held 443,181 shares, which include RSUs that are still subject to future vesting.
Longeveron Inc. Chief Medical Officer Nataliya Agafonova reported a tax-related share disposition. On this Form 4, 22,505 shares of Class A Common Stock were withheld at $0.7291 per share to cover tax obligations tied to the vesting of a restricted stock unit award. After this tax-withholding event, she holds 430,914 shares directly, which includes restricted stock units that remain subject to future vesting.
Longeveron Inc. executive Devin Blass, CTO & SVP of CMC, reported a routine tax-withholding disposition related to equity compensation. On the reported date, 15,808 shares of Class A Common Stock were withheld at $0.7291 per share to satisfy tax obligations from vesting restricted stock units. Following this non-market transaction, Blass holds 425,735 shares directly, which the footnotes state include RSUs subject to future vesting.
Longeveron Inc. General Counsel and Secretary Paul T. Lehr reported a routine tax-related share disposition. On July 1, 2026, 13,143 shares of Class A Common Stock were withheld at an effective price of $0.7291 per share to satisfy tax obligations from the vesting of a restricted stock unit (RSU) award. This was an automatic tax-withholding event, not an open-market sale.
After this transaction, Lehr directly held 575,423 shares of Longeveron Class A Common Stock, which the filing notes includes RSUs that are still subject to future vesting. The filing shows no option exercises or open-market purchases or sales by Lehr in this report.
Lehr Paul T reported acquisition or exercise transactions in this Form 4 filing.
Longeveron Inc. reported that General Counsel and Secretary Paul T. Lehr received an equity grant of 250,000 shares of Class A common stock as a time-based vesting Restricted Stock Unit (RSU) award. The filing notes that Lehr’s holdings, including RSUs subject to future vesting, total 588,566 shares after this grant.
Willard Stephen H reported acquisition or exercise transactions in this Form 4 filing.
Longeveron Inc. Chief Executive Officer Willard Stephen H received an equity compensation award of 500,000 shares of Class A Common Stock on May 1, 2026. The award is structured as time-based vesting Restricted Stock Units (RSUs) granted at a stated price of $0.00 per share, so it is not an open-market purchase.
Following this grant, his directly held position in Longeveron Class A Common Stock is reported as 789,727 shares, which includes RSUs that are still subject to future vesting conditions.
Longeveron Inc. reported that CTO & SVP of CMC Devin Blass acquired 250,000 shares of Class A Common Stock on a grant/award basis. The shares were awarded as time-based vesting Restricted Stock Units, and total direct holdings increased to 441,543 shares, including RSUs subject to future vesting.
Longeveron Inc. reported that Chief Medical Officer Nataliya Agafonova acquired 250,000 shares of its Class A Common Stock through an award of time-based vesting Restricted Stock Units (RSUs) on May 1, 2026 at a stated price of $0.00 per share.
After this RSU award, she directly holds 453,419 Class A shares, which include RSUs subject to future vesting. The award reflects a non-cash equity grant classified as a grant, award, or other acquisition under insider reporting rules.
Locklear Lisa reported acquisition or exercise transactions in this Form 4 filing.
Longeveron Inc. Chief Financial Officer Lisa Locklear received an award of 250,000 shares of Class A Common Stock as time-based vesting Restricted Stock Units (RSUs). The grant was recorded at $0.00 per share, reflecting a compensation award rather than an open-market purchase.
After this award, Locklear directly holds 465,686 shares of Class A Common Stock, which the footnotes state includes RSUs that are still subject to future vesting conditions.
Longeveron Inc. General Counsel and Secretary Paul T. Lehr reported a routine tax-related share disposition. On the vesting of a restricted stock unit award, 5,611 shares of Class A common stock were withheld at $1.12 per share to satisfy tax obligations.
Following this tax-withholding event, Lehr directly holds 338,566 shares of Class A common stock, which the disclosure notes includes restricted stock units that are subject to future vesting.
Longeveron Inc. Chief Medical Officer Nataliya Agafonova reported a routine tax-related share disposition. On the vesting of a restricted stock unit award, 13,145 shares of Class A common stock were withheld at $1.12 per share to satisfy tax obligations, rather than sold in the open market.
After this withholding, she directly holds 203,419 shares of Class A common stock, which includes RSUs that are still subject to future vesting. The filing reflects compensation-related share vesting mechanics, not an active decision to buy or sell shares.
Longeveron Inc. Chief Financial Officer Lisa Locklear reported a routine tax-related share disposition. On April 1, 2026, 13,145 shares of Class A Common Stock were withheld at $1.12 per share to satisfy tax obligations tied to vesting of a restricted stock unit award.
After this withholding, Locklear directly holds 215,686 shares of Class A Common Stock, which the disclosure states includes RSUs that are still subject to future vesting. The filing does not show any open-market buying or selling activity.
Longeveron Inc. Chief Executive Officer Willard Stephen H reported a routine tax-related share transaction. On the vesting of a restricted stock unit (RSU) award, 4,740 shares of Class A Common Stock were withheld at $1.12 per share to satisfy tax obligations, rather than being sold in the open market.
Following this tax-withholding disposition, he directly holds 289,727 shares of Class A Common Stock, which includes RSUs subject to future vesting.
Longeveron Inc. executive Devin Blass, CTO & SVP of CMC, reported a routine share disposition related to taxes rather than an open-market trade. On the vesting of a restricted stock unit award, 8,633 shares of Class A Common Stock were withheld at $1.12 per share to satisfy tax obligations. After this tax-withholding event, Blass directly holds 191,543 shares of Class A Common Stock, including RSUs that remain subject to future vesting.
Longeveron Inc. reported that Chief Executive Officer Willard Stephen H received several equity awards. He was granted a stock option for 200,000 shares of Class A common stock at an exercise price of $0.545 per share, vesting quarterly over four years beginning on April 1, 2026.
He also received an initial hire award of 200,000 shares of Class A common stock, with 105,533 of those shares withheld to cover tax obligations. In addition, he was granted 200,000 time-based vesting RSUs. Following these awards and tax withholding, he directly holds 294,467 shares of Class A common stock, which includes RSUs subject to future vesting.
Longeveron Inc. Chief Medical Officer Nataliya Agafonova reported a Form 4 transaction involving company Class A common stock. On 01/02/2026, 10,250 shares were withheld at a price of $0.593 per share, identified with transaction code "F," which the footnotes explain were shares withheld to satisfy tax obligations arising from the vesting of a restricted stock unit (RSU) award. Following this tax withholding, she beneficially owned 216,564 shares in total, which the disclosure notes includes RSUs that are still subject to future vesting.
Longeveron Inc. officer reports routine tax withholding transaction. General Counsel and Secretary Paul T. Lehr filed a Form 4 for a transaction on 01/02/2026 involving Class A Common Stock of Longeveron Inc. (LGVN).
The filing shows that 6,952 shares were withheld at a price of $0.593 per share to satisfy tax obligations tied to the vesting of a restricted stock unit (RSU) award. Following this tax withholding, Lehr beneficially owned 344,177 shares, which include RSUs that are subject to future vesting. This reflects an administrative equity compensation event rather than an open-market purchase or sale.
Longeveron Inc. Chief Financial Officer Lisa Locklear reported an insider transaction involving Class A Common Stock. On 01/02/2026, 10,250 shares were withheld at $0.593 per share to satisfy tax obligations in connection with the vesting of a restricted stock unit (RSU) award, rather than an open-market sale. Following this tax withholding, she beneficially owned 228,831 shares, which include RSUs subject to future vesting.
Longeveron Inc. Chief Executive Officer James Nathaniel Powell reported a routine tax-related transaction in the company’s Class A common stock. On 01/02/2026, 2,464 shares were withheld at a price of $0.593 per share to satisfy tax obligations arising from the vesting of a restricted stock unit (RSU) award.
After this withholding, Powell beneficially owned 125,593 shares of Longeveron Class A common stock on a direct basis, which includes RSUs that remain subject to future vesting.
Longeveron Inc. (LGVN) reported an insider equity award. A director acquired 34,000 shares of Class A common stock on 10/01/2025, recorded at a $0 price, as part of a time-based vesting RSU award.
Following the transaction, the reporting person beneficially owned 34,000 shares, held directly. The filing notes the holdings include RSUs subject to future vesting.
Nataliya Agafonova, Chief Medical Officer of Longeveron Inc. (LGVN), reported a transaction dated 10/01/2025 on Form 4 showing a sale of 11,883 shares of Class A common stock at a price of $0.7424 per share.
After the reported disposition, the filing shows Agafonova beneficially owns 226,814 shares, which the filer states includes restricted stock units (RSUs) subject to future vesting. The filing also explains that 11,883 shares were withheld to satisfy tax obligations arising from the vesting of an RSU award.
Longeveron (LGVN) CEO reported a routine insider transaction on a Form 4. On 10/01/2025, 2,389 shares of Class A common stock were withheld at $0.7424 to cover taxes upon the vesting of a restricted stock unit award. Following this tax withholding, the reporting person beneficially owned 128,057 shares. The filing notes the balance includes RSUs subject to future vesting.
Longeveron Inc. (LGVN) reported an insider transaction by its General Counsel and Secretary. On 10/01/2025, the officer had 4,944 shares of Class A common stock withheld to cover taxes upon RSU vesting (transaction code F) at $0.7424 per share.
Following the transaction, the officer beneficially owns 351,129 shares directly. The holding includes RSUs subject to future vesting, as noted in the footnotes.
Longeveron (LGVN) reported an insider equity transaction by its CTO & SVP of CMC. On 10/01/2025, the officer had 7,609 shares of Class A common stock withheld under transaction code F to cover taxes upon the vesting of a restricted stock unit (RSU) award at a price of $0.7424 per share. Following this tax withholding, the officer beneficially owned 210,876 shares, which includes RSUs subject to future vesting.
Longeveron (LGVN) filed a Form 4 for its CFO reporting an administrative share transaction tied to equity compensation. On 10/01/2025, 11,883 shares of Class A common stock were withheld at a price of $0.7424 to satisfy tax obligations upon the vesting of a restricted stock unit (RSU) award, coded “F.”
Following this transaction, the reporting person beneficially owned 239,081 shares, which includes RSUs subject to future vesting. The filing indicates direct ownership.